This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.

this is a navigational image map, please load this image to continue.
Next Last Index Home
Slide 1 of 14
 
Prostate specific antigen (PSA) has for 20 years been widely used as a screening test for prostate cancer, and it was once called, ‘the most meaningful and useful tumor marker in all of cancer biology (T.A. Stamey, Monogr.Urol. 10: 45, 1989).’ However, experience over the past 2 decades has somewhat dampened the early enthusiasm for use of PSA as a screening test. In the following slides, we outline the 10 great foibles of using PSA as a screening test for prostate cancer. NOTE: The value of PSA in the follow-up of men who have already been diagnosed has never been challenged.

this is a navigational image map, please load this image to continue.